Nitric oxide activation of peroxisome proliferator‐activated receptor gamma through a p38 MAPK signaling pathway
Open Access
- 28 December 2006
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 21 (3) , 950-961
Abstract
Both nitric oxide (NO · ) and peroxisome proliferator‐activated receptors (PPARs) protect the endothelium and regulate its function. Here, we tested for crosstalk between these signaling pathways. Human umbilical vein and hybrid EA.hy926 endothelial cells were exposed to S‐nitrosoglutathione (GSNO) or dieth‐ylenetriamine NONOate (DETA NONOate). Electro‐phoretic mobility shift assays using PPAR‐response element (PPRE) probe showed that NO · caused a rapid dose‐dependent increase in PPARγ binding, an effect that was confirmed in vivo by chromatin immunopre‐cipitation. Conversely, N G monomethyl‐L‐arginine, a NOS inhibitor, decreased PPARγ binding. NO · ‐medi‐ated PPARγ binding and NO · induction of cyclooxy‐genase‐2 (COX‐2), diacylglycerol (DAG) kinase alpha (DGKx), and heme oxygenase‐1 (HO‐1), genes with well‐characterized PPRE motifs, were cGMP independent. NO · dose dependently activated p38 MAPK, and p38 MAPK inhibition with SB202190 or knockdown with siRNA was shown to block NO · activation of PPARγ. Likewise, p38 MAPK and PPARγ inhibitors or knockdown of either transcript all significantly blocked NO · induction of PPRE‐regulated genes. PPARγ activation by p38 MAPK may contribute to the anti‐inflammatory and cytoprotective effects of NO · in the vascu‐lature. This crosstalk mechanism suggests new strategies for preventing and treating vascular dysfunction.Ptasinska, A., Wang, S., Zhang, J., Wesley, R. A., Danner, R. L. Nitric oxide activation of peroxisome proliferator‐activated receptor gamma through a p38 MAPK signaling pathway. FASEB J. 21, 950–961 (2007)Keywords
This publication has 47 references indexed in Scilit:
- Nitric oxide activation of Erk1/2 regulates the stability and translation of mRNA transcripts containing CU-rich elementsNucleic Acids Research, 2006
- Nitric oxide post-transcriptionally up-regulates LPS-induced IL-8 expression through p38 MAPK activationJournal of Leukocyte Biology, 2004
- Peroxisome Proliferator-Activated Receptors and AtherogenesisCirculation Research, 2004
- Differential Roles of Smad1 and p38 Kinase in Regulation of Peroxisome Proliferator-activating Receptor γ during Bone Morphogenetic Protein 2-induced AdipogenesisMolecular Biology of the Cell, 2003
- Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γCirculation Research, 2002
- 85-kDa Cytosolic Phospholipase A2 Mediates Peroxisome Proliferator-activated Receptor γ Activation in Human Lung Epithelial CellsJournal of Biological Chemistry, 2002
- Constitutive Activation of Peroxisome Proliferator-activated Receptor-γ Suppresses Pro-inflammatory Adhesion Molecules in Human Vascular Endothelial CellsJournal of Biological Chemistry, 2002
- Cyclooxygenase-2 Is Induced in Monocytes by Peroxisome Proliferator Activated Receptor γ and Oxidized Alkyl Phospholipids from Oxidized Low Density LipoproteinJournal of Biological Chemistry, 2002
- Nitric Oxide Increases Tumor Necrosis Factor Production in Differentiated U937 Cells by Decreasing Cyclic AMPJournal of Biological Chemistry, 1997
- Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγScience, 1996